U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data analysis and interpretation

Communications in Clinical Cytometry

Volumn 30, Issue 5, 1997, Pages 236-244

  Borowitz, Michael J ^a   Bray, Robert ^b   Gascoyne, Randy ^c   Melnick, Steven ^d   Parker, John W ^e   Picker, Louis ^f   Stetler Stevenson, Maryalice ^g  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d MIAMI CHILDREN'S HOSPITAL   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; ANALYTIC METHOD; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANADA; CELL POPULATION; CONFERENCE PAPER; DATA ANALYSIS; FLOW CYTOMETRY; HAIRY CELL LEUKEMIA; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPHENOTYPING; LYMPHOBLASTOMA; LYMPHOCYTOMA; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; MYCOSIS FUNGOIDES; MYELODYSPLASIA; NEOPLASM; NONHODGKIN LYMPHOMA; PLASMACYTOMA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SEZARY SYNDROME; T CELL LYMPHOMA; UNITED STATES;

ANTIGENS, NEOPLASM; CANADA; DATA INTERPRETATION, STATISTICAL; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA; UNITED STATES;

EID: 0030828712     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19971015)30:5<236::AID-CYTO4>3.0.CO;2-F     Document Type: Conference Paper

References (115)

1. Adriaansen HJ, te Boekhorst PA. Hagemeijer AM, van der Schoot CE, Delwel HR, van Dongen JJ: Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 81:3043-3051, 1993.
2. Alkan S, Schnitzer B, Thompson JL, Moscinski LC, Ross CW: Cyclin DI protein expression in mantle cell lymphoma. Ann Oncol 6:567-570, 1995.
3. Almasri N, Duque R, Iturraspe J, Everett E, Braylan R: Reduced expression of CD20 antigen as a characteristic marker for chronic lympliocytic leukemia. Amer J Hematol 40:259, 1992.
4. Ansari MQ, Dawson DB, Nador R, Rutherford C, Schneider NR, Latimer MJ, Picker L, Knowles DM, McKcnna RW: Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 105:221-229, 1996.
5. Astsaturov IA, Matutes E, Morilla R, Seon BK, Mason DY, Farahat N, Catovsky D: Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia. Leukemia 10: 769-773, 1996.
6. Baldini L, Cro L, Cortelezzi A, Calori R, Nobili L, Maiolo AT, Polli EE: Imnunophenotypes in "classical" B-cell chronic Iymphocytic leukemia: Correlation with normal cellular counterpart and clinical findings. Cancer 66:1738-1742, 1990.
7. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, et al.: Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16:637-640, 1992.
8. Batata A, Shen B: Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia: A study of 242 cases. Cancer 70:2436-2443, 1992.
9. Batata A, Shen B: Relationship between chronic lymphocytic leukemia and small lymphocytic lymphoma: A comparative study of membrane phenotypes in 270 cases. Cancer 70:625-632, 1992.
10. Baumann MA, Keller RH, McFadden PW, Libnoch JA, Patrick CW: Myeloid cell surface phenotype in myelodysplasia: Evidence for abnormal persistence of an early myeloid differentiation antigen. Am J Hematol 22:251-257, 1986.
11. Behm FG, Raimondi SC, Schell MJ, Look AT, Rivera GK, Pui CH: Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features. Blood 79:1011-10116, 1992.
12. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB: Proposals for the immunological classification of acute leukemias: European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9:1783-1786, 1995.
13. Betz SA, Foucar K, Head DR, Chen IM, Willman CL: False-positive flow cytometric platelet glycoprotein Hb/IIIa expression in myeloid leukemias secondary to platelet adherence to blasts. Blood 79:2399-2403, 1992.
14. Bonde J, Meyer K, Broe MK, Hokland M, Turley H. Hokland P: Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13, CD14 and CD66 monoclonal antibodies. Br J Haematol 92:269-279, 1996.
15. Borowitz MJ, Guenther KL, Shults KE, Stelzer GT: Immunophenotyping of acute leukemia by flow cytometric analysis: Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 100:534-540, 1993.
16. Braylan RC, Bauer KD, Duque RE, Shankey TV (eds): Clinical Flow Cytometry. Williams & Wilkins, Baltimore. 1993, pp 203-34.
17. Braylan RC, Benson NA, Iturraspe J: Analysis of lymphomas by flow cytometry. Current and emerging strategies. Ann NY Acad Sci 677:364-378, 1993.
18. Campana D: Monitoring minimal residual disease in acute leukemia: Expectations, possibilities and initial clinical results. Int J Clin Lab Res 24:132-138, 1994.
19. Campana D, Pui CH: Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 85:1416-1434, 1995.
20. Chan WC, Gu LB, Masih A, Nicholson J, Vogler WR, Yu G, Nasr S: Large granular lymphocyte proliferation with the natural killer-cell phenotype. Am J Clin Pathol 97:353-358, 1992.
21. Chen SS, Zhang HF, Xuc WT, Li K, Fu JF, Wang DB, Wu PN: Aberration antigen expression in adult acute myelocytic leukemias. Chin Med J Engl 106:419-422, 1993.
22. Coustan Smith E, Behm FG, Hurwitz CA, Rivera GK, Campana D: N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia. Leukemia 7:853-858, 1993.
23. Crist WM, Shuster JJ, Falletta J, Pullen DJ, Berard CW, Vietti TJ, Alvarado CS, Roper MA, Prasthofer E, Grossi CE: Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: A Pediatric Oncology Group Study. Blood 72:1891-1897, 1988.
24. Davis RE, Longacre TA, Cornbleet PJ: Hematogones in the bone marrow of adults. Immunophenotypic features, clinical settings, and differential diagnosis. Am J Clin Pathol 102:202-211, 1994.
25. Del Poeta G, Stasi R, Aronica G, Venditti A, Cox MC, Bruno A, Buccisano F, Masi M, Tribalto M, Amadori S, et al.: Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Blood 87:1997-2004, 1996.
26. Dierlamm J, Pittaluga S, Wlodarska I, Stul M, Thomas J, Boogaerts M, Michaux L, Driessen A, Mecucci C, Cassiman JJ, et al.: Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 87:299-307, 1996.
27. Drach D, Drach J, Glassl II, Gattringer C, Huber H: Flow cytometric detection of cytoplasmic antigens in acute leukemias: implications for lineage assignment. Leuk Res 17:455-461, 1993.
28. Dubosc Marchenay N, Lacombe F, Dumain P, Marit G, Montastruc M, Belloc F, Reiffers J: Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia. Hematol Oncol 10:235-249, 1992.
29. Duque RE: Interactive data analysis for evaluation of B-cell neoplasia by flow cytometry. Methods Cell Biol 42 Pt B:231-242, 1994.
30. Felzmann T, Gisslinger H, Krieger O, Majdic O, Ludwig H, Koller U: Immunophenotypic characterization of myelomonocytic cells in patients with myelodysplastic syndrome. Br J Haematol 84:428-435, 1993.
31. Ferrara F, Del Vecchio L: Clinical relevance of acute mixed-lineage leukemias. Leuk Lymphoma 12:11-19, 1993.
32. Ferry JA, Yang WI, Zukerberg LR, Wotherspoon AC, Arnold A, Harris NL: CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse. Am J Clin Pathol 105:31-37, 1996.
33. Freedman AS, Nadler LM: Immunologic markers in non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 5:871-889, 1991.
34. Geisler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, Nielsen H, Plesner T, Thorling K, Andersen E, et al.: Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 78:1795-1802, 1991.
35. Ginaldi L, Matutes E, Farahat N, De Martinis M, Morilla R, Catovsky D: Differential expression of CD3 and CD7 in T-cell malignancies: a quantitative study by flow cytometry. Br J Haematol 93:921-927, 1996.
36. Hanson CA, Gribbin TE, Schnitzer B, Schlegelmilch JA, Mitchell BS, Stoolman LM; CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood 76:2360-2367. 1990.
37. Harada H, Kawano MM, Huang N, Harada Y, Iwato K, Tanabe O, Tanaka H, Sakai A, Asaoku H, Kuramoto A: Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 81:2658-2663, 1993.
38. Harris NL, Jaffe ES, Stein II, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf Peeters C, Falini B, Gatter KC, et al.: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994.
39. Hassan IB, Hagberg H, Sundstrom C: Immunophenotype of hairy-cell leukemia. Eur J Haematol 45:172-176, 1990.
40. Hastrup N, Ralfkiaer E, Pallesen G: Aberrant phenotypes in peripheral T cell lymphomas. J Clin Pathol 42:398-402, 1989.
41. Hill RB, Goodale F: The Delphi predictions of pathology chairmen: a six-year retrospective view. J Med Educ 56:537-546, 1981.
42. Huh YO, Andreeff M: Flow cytometry: Clinical and research applications in hematologic malignancies mematol. Oncol Clin North Am 8:703-723, 1994.
43. Huh YO, Pugh WC, Kantarjian HM, Stass SA, Cork A, Trujillo JM, Keating MJ: Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody. Am J Clin Pathol 101:283-289, 1994.
44. Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro J, Jr, Kalwinsky DK, Ayers GD, Behm FG: Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 80:3182-3188, 1992.
45. Jacobs JC, Katz RL, Shabb N, el Naggar A. Ordonez NG, Pugh W: Fine needle aspiration of lymphoblastic lymphoma. A multiparameter diagnostic approach. Acta Cytol 36:887-894, 1992.
46. Janossy G, Coustan Smith E, Campana D: The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: A study of 500 cases. Leukemia 3:170-181, 1989.
47. Jensen IM: Myelopoiesis in myelodysplasia evaluated by multiparameter flow cytometry. Leuk Lymphoma 20:17-25, 1995.
48. Kilo MN. Dorfman DM: The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/ chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol 105:451-457, 1996.
49. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S, Tanaka I, Ohta C, Tsutani H, Oguma S, et al.: Clinical importance of CD7 expression in acute myelocytic leukemia: The Japan Cooperative Group of Leukemia/Lymphoma. Blood 81:2399-2405, 1993.
50. Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, et al.: Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80:470-477, 1992.
51. Kristensen JS, Ellegaard J, Hokland P: A two-color flow cytometry assay for detection of hairy cells using monoclonal antibodies. Blood 70:1063-1068, 1987.
52. Kuchnio M, Sausville EA, Jaffe ES, Greiner T, Foss FM, McClanahan J, Fukushima P, Stetler Stevenson MA: Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of T-cell receptor expression. Am J Clin Pathol 102:856-860, 1994.
53. Kwong YL, Robertson EP, Lee CP, Chan LC: Dual-color flow cytometric analysis of megakaiyocytic DNA ploidy in the investigation of blastic phase chronic myelogenous leukemia with rearrangement of 3q26. Cancer 71:3882-3887, 1993.
54. Launder TM, Bray RA, Stempora L, Chenggis ML, Farhi DC: Lymphoidassociated antigen expression by acute myeloid leukemia. Am J Clin Pathol 106:185-191, 1996.
55. Lavabre Bertrand T, Duperray C, Brunet C, Poncelet P, Exbrayat C, Bourquard P, Lavabre Bertrand C, Brochier J, Navarro M, Janossy G: Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias. Leukemia 8:402-408, 1994.
56. Lavabre Bertrand T, Janossy G, Ivory K, Peters R, Secker Walker L, Porwit MacDonald A: Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression. Cytometry 18:209-217, 1994.
57. Legac E, Autran B, Merle Beral H, Katlama C, Debre P: CD4+CD7-CD57+ T cells: A new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood 79:1746-1753, 1992.
58. Little JV, Foucar K, Horvath A, Crago S: Flow cytometric analysis of lymphoma and lymphoma-like disorders. Semin Diagn Pathol 6:37-54, 1989.
59. Lo Coco F, Avvisati G, Diverio D, Biondi A, Pandolfi PP, Alcalay M, De Rossi G, Petti MC, Cantu Rajnoldi A, Pasqualetti D, et al.: Rearrangements of the RAR-alpha gene in acute promyelocytic leukaemia: Correlations with morphology and immunophenotype. Br J Haematol 78:494-499, 1991.
60. Macedo A, Orfao A, Gonzalez M, Vidriales MB, Lopez Berges MC, Martinez A, San Miguel JF: Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: Implications for minimal residual disease studies. Leukemia 9:993-998, 1995.
61. Macedo A, Orfao A, Martinez A, Vidriales MB, Valverde B, Lopez Berges MC, San Miguel JF: Immunophenotype of c-kit cells in normal human bone marrow: Implications for the detection of minimal residual disease in AML. Br J Haematol 89:338-341, 1995.
62. Macedo A, Orfao A, Vidriales MB, Lopez Berges MC, Valverde B, Gonzalez M, Caballero MD, Ramos F, Martinez M, Fernandez Calvo J, et al.: Characterization of aberrant phenotypes in acute myeloblastic leukemia. Ann Hematol 70:189-194, 1995.
63. Macey MG: Flow-cytometric analysis of lymphocytes, leukaemias and lymphomas. Br J Biomed Sci 50:334-349, 1993.
64. Maeda K, Alessio RC, Hawley RC: Recent advances in diagnosis of leukemia. Jpn J Clin Oncol 23:79-84, 1993.
65. Marti G, Faguet G, Bertin P, Agee J, Washington G, Ruiz S. Carter P, Zenger V, Vogt R, Noguchi P: CD20 and CD5 expression in B-chronic lymphocytic leukemia. Ann Ny Acad Sci 651:480, 1992.
66. Marti GR, Zenger V, Caproaso NE, Brown M, Washington GC, Carter P, Schlechter G, Noguchi P: Antigenic expression of B-cell chronic lymphocytic leukemic lymphocytes. Anal Quant Cytol Histol 11:315-323, 1989.
67. Martinsson U, Sundstrom C, Glimelius B: Immunophenotype analysis of B-CLL lymphoma and immunocytoma. APMIS 97:1025-1032, 1989.
68. Matutes E, Morilla R, Owusu Ankomah K, Houliham A, Meeus P, Catovsky D: The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma 14 Suppl 1:57-61, 1994.
69. Matutes E, Owusu Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D: The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8:1640-1645, 1994.
70. Merle Beral H: A further characterization of B-CLL lymphocytes: phenotypic and functional studies. Nouv Rev Fr Hematol 32:319-321, 1990.
71. Miwa H, Nakase K, Kita K: Biological characteristics of CD7(+) acute leukemia. Leuk Lymphoma 21:239-244, 1996.
72. Moll M, Reinhold U, Kukel S, Abken H, Muller R, Oltermann I, Kreysel HW: CD7-negative helper T cells accumulate in inflammatory skin lesions. J Invest Dermatol 102:328-332, 1994.
73. Molot R, Meeker T, Wittwer C, Pcrkins S, Segal G, Masih A, Braylan R, Kjeldsberg C: Antigen expression and polymerasc chain reaction amplification of mantle cell lymphomas. Blood 83:1626-1631, 1994.
74. Moscinski LC, So AL, Russell JE, Kant JA, Prystowsky MB: Myeloperoxidase-positive acute megakaryoblastic leukemia. Am J Clin Pathol 91:607-612, 1989.
75. Nadler LM, Korsmeyer SJ, Anderson KC, Boyd AW, Slaughenhoupt B, Park E, Jensen J, Coral F, Mayer RJ, Sallan SE, et al.: B cell origin of non-T cell acute lymphoblastic leukemia: A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest 74:332-340, 1984.
76. Nasu K, Said J, Vonderheid E, Olerud J, Sako D, Kadin M: Immunopathology of cutaneous T-cell lymphomas. Am J Pathol 119:436-447, 1985.
77. Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH: The immunophenotype of acute promyelocytic leukemia (APL): An ECOG study. Leukemia 8:1108-1112, 1994.
78. Penchansky L, Kaplan SS, Krause JR: Multiple lineage reactivity in childhood leukemia. Pediatr Pathol 10:217-229, 1990.
79. Peters RE, Janossy G, Ivory K, al Ismail S, Mercolino T: Leukemia-associated changes identified by quantitative flow cytometry: III. B-cell gating in CD37/kappa/lambda clonality test. Leukemia 8:1864-1870, 1994.
80. Picker LJ, Weiss LM, Medeiros LJ, Wood GS, Warnke RA: Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 128:181-201, 1987.
81. Pui CH, Behm FG, Singh B, Schell MJ, Williams DL, Rivera GK, Kalwinsky DK, Sandlund JT, Crist WM, Raimondi SC: Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood 75:174-179, 1990.
82. Pui CH, Dahl GV, Melvin S, Williams DL, Peiper S, Mirro J, Murphy SB, Stass S: Acute leukaemia with mixed lymphoid and myeloid phenotype. Br J Haematol 56:121-130, 1984.
83. Pui CH, Rivera GK, Hancock ML, Raimondi SC, Sandlund JT, Mahmoud HH, Ribeiro RC. Furman WL, Hurwitz CA, Crist WM, et al.: Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. Leukemia 7:35-40, 1993.
84. Quintanilla Martinez L, Zukerberg LR, Ferry JA, Harris NL: Extramedullary tumors of lymphoid or myeloid blasts. The role of immunohistology in diagnosis and classification. Am J Clin Pathol 104:431-443, 1995.
85. Raife TJ, Lager DJ, Kemp JD, Dick FR: Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia. Am J Clin Pathol 101:296-299, 1994.
86. Raphael MM, Audouin J, Lamine M, Delecluse HJ, Vuillaume M, Lenoir GM, Gisselbrecht C, Lennert K, Diebold J: Immunophenotypic and genotypic analysis of acquired immunodeficiency syndromerelated non-Hodgkin's lymphomas. Correlation with histologic features in 36 cases: French Study Group of Pathology for HIV-Associated Tumors. Am J Clin Pathol 101:773-782, 1994.
87. Richard G, Brody J, Sun T: A case of acute megakaryocytic leukemia with hematogones. Leukemia 7:1900-1903, 1993.
88. Robbins BA, Ellison DJ, Spinosa JC, Carey CA. Lukes RJ, Poppema S, Saven A, Piro LD: Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 82:1277-1287, 1993.
89. Ruiz Arguelles GJ, San Miguel JF: Cell surface markers in multiple myeloma. Mayo Clin Proc 69:684-690, 1994.
90. San Miguel JF, Gonzalez M, Canizo MC, Anta JP, Zola H, Lopez Borrasca A: Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification. Br J Haematol 64:547-560, 1986.
91. Segal GH, Edinger MG, Owen M, McNealis M, Lopez P, Perkins A, Linden MD. Fishleder AJ, Stoler MH, Tubbs RR: Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry. Cytometry 12:350-359, 1991.
92. Shikano T, Arioka H, Kobayashi R, Naito H, Ishikawa Y, Nakadate H, Hatae Y, Takeda T: Acute lymphoblastic leukemia and non-Hodgkin's lymphoma with mediastinal mass - a study of 23 children: different disorders or different stages? Leuk Lymphoma 13:161-167, 1994.
93. Sievers EL, Loken MR: Detection of minimal residual disease in acute myelogenous leukemia. J Pediatr Hematol Oncol 17:123-133, 1995.
94. Sobol RE, Bloomfield CD, Royston I: Immunophenotyping in the diagnosis and classification of acute lymphoblastic leukemia. Clin Lab Med 8:151-162, 1988.
95. Stasi R, Del Poeta G, Vendilti A, Bruno A, Suppo G, Aronica G, Di Carlo G, Papa G: Lineage identification of acute leukemias: Relevance of immunologic and ultrastructural techniques. Hematol Pathol 9:79-94, 1995.
96. Stelzer GT, Shults KE, Loken MR: CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann NY Acad Sci 677:265-280, 1993.
97. Sulak LE, Clare CN, Morale BA, Hansen KL, Montiel MM: Biphenotypic acute leukemia in adults. Am J Clin Pathol 94:54-58, 1990.
98. Sun T, Ngu M, Henshall J, Cuomo J, Eisenberg A, Benn P. Allen SL: Marker discrepancy as a diagnostic criterion for lymphoid neoplasms. Diagn Clin Immunol 5:393-399, 1988.
99. Terstappen LW, de Grooth BG, van Berkel W, ten Napel CH, Greve J: Flow cytometric characterization of chronic lymphocyte leukaemias using orthogonal light scattering and quantitative immunofluorescence. Blut 56:201-208, 1988.
100. Terstappen LW, Safford M, Konemann S, Loken MR. Zurlutter K, Buchner T, Hiddemann W, Wormann B: Flow cytometric characterization of acute myeloid leukemia Part II. Phenotypic heterogeneity at diagnosis. Leukemia 6:70-80, 1992.
101. Terstappen LW, Safford M, Unterhalt M, Konemann S, Zurlutter K, Piechotka K, Drescher M, Aul C, Buchner T, Hiddemann W, et al.: Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells. Leukemia 6:993-1000, 1992.
102. Thiel E, Kranz BR, Raghavachar A, Bartram CR, Loffler H, Messerer D, Ganser A, Ludwig WD, Buchner T, Hoelzer D: Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood 73: 1247-1258, 1989.
103. Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D: CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Leukemia 9:249-253, 1995.
104. Thomas X, Campos L, Archimbaud E, Shi ZH, Treille Ritouet D, Anglaret B, Fiere D: Surface marker expression in acute myeloid leukaemia at first relapse. Br J Haematol 81:40-44, 1992.
105. van Wering ER, Beishuizen A, Roeffen ET, van der Linden Schrever BE, Verhoeven MA, Hahlen K, Hooijkaas H, van Dongen JJ: Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. Leukemia 9:1523-1533, 1995.
106. Vaughan WP, Civin CI, Weisenburger DD, Karp JE, Graham ML, Sanger WG, Grierson HL, Joshi SS, Burke PJ: Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). Leukemia 2:661-666, 1988.
107. Vidriales MB, Orfao A, Lopez Berges MC, Gonzalez M, Lopez Macedo A, Garcia MA, Galende J, San Miguel JF: Light scatter characteristics of blast cells in acute myeloid leukaemia: Association with morphology and immunophenotype. J Clin Pathol 48:456-462, 1995.
108. Wells SJ, Bray RA, Stempora LL, Farhi DC: CD117/CD34 expression in leukemic blasts. Am J Clin Pathol 106:192-195, 1996.
109. Wilson JF, Kjeldsberg CR, Sposto R, Jenkin RD, Chilcote RR, Coccia P, Exelby RR, Kersey J, Meadows A, Siegel S, et al.: The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's). Hum Pathol 18:1008-1014, 1987.
110. Witzig TE, Kimlinger TK, Greipp PR: Detection of peripheral blood myeloma cells by three-color flow cytometry. Curr Top Microbiol Immunol 194:3-8, 1995.
111. Witzig TE, Li CY, Tefferi A, Katzmann JA: Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia. Am J Clin Pathol 101:312-317, 1994.
112. Wormann B, Safford M, Konemann S, Buchner T, Hiddemann W, Terstappen LW: Detection of aberrant antigen expression in acute myeloid leukemia by multiparameter flow cytometry. Recent Results Cancer Res 131:185-196, 1993.
113. Wormsley SB, Baird SM, Gadol N, Rai KR, Sobol RE: Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes. Blood 76:123-130, 1990.
114. Wu CD, Jackson CL, Medeiros LJ: Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases. Am J Clin Pathol 105:277-285, 1996.
115. Young IT: Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem 25:935-941, 1977.